HEXO HEXO Corp.

The Hydropothecary Corp is in the business of producing, marketing and selling of medical marijuana through its indirect wholly-owned subsidiary. The product lines include H2, Decarb, and Elixir No. 1.

Note: This is not a U.S. company, but they cross-list their shares on a U.S. stock exchange - see the related symbol CT:HEXO.

$7.30  -0.01 (-0.14%)
As of 03/02/2021 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Drug Manufacturers—Specialty &
Canada

01/08/2013
122,162,687
8,829,706
$893,009,242
0.00%
SEC Edgar Online
40-F



Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-1.82
1.62
8.10
-88.81%
-444.86%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy